Publications by authors named "Sheena K Aurora"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

8,775

Total Likes

142

Extended Reach

318,980

Social Features

71
A
A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.
Sheena K Aurora, Stephen B Shrewsbury, Sutapa Ray, Nada Hindiyeh, Linda Nguyen

April 2021

Videos about Article: user user

2 1 6 48 14

View All Article and Social Media Activity
C
CGRP and the Trigeminal System in Migraine.
Smriti Iyengar, Kirk W Johnson, Michael H Ossipov, Sheena K Aurora

Headache· May 2019

Videos about Article: user user

2 18 8

View All Article and Social Media Activity
R
Reaching international consensus on the definition of refractory migraine using the Delphi method.
Jennifer Robblee, Fawad A Khan, Michael J Marmura, Hope L O'Brien, Lawrence D Robbins, Sheena K Aurora

Cephalalgia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab.
Hans-Christoph Diener, Kathleen A Day, Sarah Lipsius, Sheena K Aurora, Nada A Hindiyeh

J Headache Pain· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine.
Rima M Dafer, Gretchen E Tietjen, John F Rothrock, Robert E Vann, Stephen B Shrewsbury, Sheena K Aurora

Headache· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline demographics and disease characteristics of patients with episodic or chronic cluster headache: data from two phase 3 randomized clinical trials in Europe and North America.
Rigmor Hoejland Jensen, Cristina Tassorelli, Tina M Myers Oakes, Jennifer N Bardos, Chunmei Zhou, Sheena K Aurora

Front Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Gut-brain Connection and Episodic Migraine: an Update.
Linda Nguyen, Nada Hindiyeh, Sutapa Ray, Robert E Vann, Sheena K Aurora

Curr Pain Headache Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay.
Lisa McConnachie, Peter J Goadsby, Robert E Vann, Sutapa Ray, Stephen B Shrewsbury, Sheena K Aurora

Front Neurol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study.
Victor S Wang, Justin Kosman, Hsiangkuo Yuan, Clinton Lauritsen, Stephen Shrewsbury, Sheena K Aurora

Headache· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INP104: a drug evaluation of a nonoral product for the acute treatment of migraine.
Amaal J Starling, Theresa Mallick-Searle, Stephen B Shrewsbury, Sheena K Aurora

Pain Manag· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.
Wade Cooper, Sutapa Ray, Sheena K Aurora, Stephen B Shrewsbury, Christopher Fuller

J Aerosol Med Pulm Drug Deliv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.
Stewart J Tepper, Jessica Ailani, Sutapa Ray, Joe Hirman, Stephen B Shrewsbury, Sheena K Aurora

J Headache Pain· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).
Joshua A Tobin, Shivang Joshi, Janet H Ford, Russell M Nichols, Shonda A Foster, Sheena K Aurora

J Med Econ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study.
Patricia Pozo-Rosich, Holland C Detke, Shufang Wang, David Doležil, Lily Q Li, Sheena K Aurora

Curr Med Res Opin· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.
Timothy R Smith, Paul Winner, Sheena K Aurora, Maria Jeleva, Jasna Hocevar-Trnka

Headache· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
Michael Ament, Kathleen Day, Virginia L Stauffer, Vladimir Skljarevski, Mallikarjuna Rettiganti, Sheena K Aurora

J Headache Pain· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal Space.
Vincent Martin, John Hoekman, Sheena K Aurora, Stephen B Shrewsbury

J Clin Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments.
Dulanji K Kuruppu, Joshua Tobin, Yan Dong, Sheena K Aurora, Laura Yunes-Medina

BMC Neurol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
David W Dodick, Erin G Doty, Sheena K Aurora, Dustin D Ruff, Virginia L Stauffer

Cephalalgia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
Michael Ament, Kathleen Day, Virginia L Stauffer, Vladimir Skljarevski, Mallikarjuna Rettiganti, Sheena K Aurora

J Headache Pain· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study.
Hu Li, Maurice Vincent, Xiang Zhang, Ellen B Dennehy, Robert Goodloe, Sheena K Aurora

Pain Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
Wim M Mulleners, Byung-Kun Kim, Miguel J A Láinez, Michel Lanteri-Minet, Patricia Pozo-Rosich, Sheena K Aurora

Lancet Neurol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.
David W Dodick, Peter J Goadsby, Christian Lucas, Rigmor Jensen, Jennifer N Bardos, Sheena K Aurora

Cephalalgia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
Jill C Rau, Edita Navratilova, Janice Oyarzo, Kirk W Johnson, Sheena K Aurora

Cephalalgia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review.
Nada Ahmad Hindiyeh, Niushen Zhang, Mallory Farrar, Pixy Banerjee, Louise Lombard, Sheena K Aurora

Headache· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review: Acupuncture vs Standard Pharmacological Therapy for Migraine Prevention.
Niushen Zhang, Tim Houle, Nada Hindiyeh, Sheena K Aurora

Headache· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis